Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2022-04-26 | Cheryl L. Cohen was nominated for election to our Board of Directors in March 2022. Since 2008, Ms. Cohen has served as President of CLC Consulting, a pharmaceutical and biotechnology consulting firm that specializes in new product start-ups and commercialization. ... Ms. Cohen currently serves on the board of directors of MEI Pharma, Immunity Bio (previously NantKwest) and Ignyte Acquisition Corp., all of which are publicly traded companies. |
| 2023-04-25 | Cheryl L. Cohen 57 2022 2 The Board of Directors has established a Compensation and Organization Development Committee currently consisting of James J. Marino, Chair, Cheryl L. Cohen and Harry H. Penner, Jr. The Board of Directors has established a Nominating and Corporate Governance Committee currently consisting of Herbert J. Conrad, Chair, Cheryl L. Cohen and Garry Neil, M.D. The following table summarizes the annual compensation for our non-employee directors during 2022. Cheryl L. Cohen Fees Earned or Paid in Cash ($) 39,505 Option Awards ($) 463,733 Total ($) 503,238 |
| 2024-04-25 | The Board of Directors has established a Compensation and Organization Development Committee currently consisting of James J. Marino, Chair, Cheryl L. Cohen and Harry H. Penner, Jr. ... The Compensation and Organization Development Committee met six times during 2023. ... The Board of Directors has established a Science and Regulatory Committee currently consisting of Garry Neil, M.D., Chair, Cheryl L. Cohen and Rita Jain, M.D. ... The amounts in the Option Awards column reflect the grant date fair value in accordance with U.S. GAAP of stock option awards made in 2023 to each of our non-employee directors for awards pursuant to the 2021 Incentive Plan subject to a vesting schedule whereby an equal number of the shares of common stock shall become vested and no longer be subject to risk of forfeiture (so long as the director remains a member of the Board as of such date). |
Data sourced from SEC filings. Last updated: 2025-08-30